The Effect of Virtual Reality on Anxiety During Intrauterine Device Insertion
1 other identifier
interventional
80
1 country
1
Brief Summary
This study was planned to determine whether the use of virtual reality glasses during intrauterine device insertion has an effect on the anxiety level of women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 12, 2023
CompletedFirst Posted
Study publicly available on registry
December 21, 2023
CompletedStudy Start
First participant enrolled
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 26, 2024
CompletedOctober 8, 2024
October 1, 2024
5 months
December 12, 2023
October 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Introductory Information Form
The form consists of questions about socio-demographic and intrauterine device insertion
between one to six months
The State/Trait Anxiety Inventory (STAI)
This inventory was developed by Spielberg in 1973 and each of the subscales ranges from 1 (not at all) to 4 (very much). The lowest and highest scores that can be obtained from each subscale are 20 and 80, respectively. Higher scores are associated with more anxiety. The alpha value of the scale varies between 0.86 and 0.92 . Öner et al. 1983, it was shown that the alpha value of the Turkish version of the STAI ranged between 0.83 and 0.87.27.
between one to six months
Visual Anolag Scale (VAS)
It was developed by Price et al. (1983) to assess the severity of pain (Price et al. 1983). It is a line, usually 10 cm long, horizontal or vertical, starting with "No Pain" and ending with "Intolerable Pain". This line may be just a straight line, or it may be divided into equal intervals, or it may have description words placed on the line to describe pain. It is generally accepted that the vertical line is easier to understand. The patient indicates the intensity of his/her pain with a mark on this line where he/she deems appropriate. The distance between the beginning of no pain and this point is measured in "cm" and recorded. Values vary between 0 and 10 and higher values indicate increased pain. Turkish validity and reliability was performed by Eti Aslan (Eti Aslan, 2004).
between one to six months
Study Arms (2)
Virtual reality group
EXPERIMENTALVirtual reality to be applied to women undergoing intrauterine device insertion.
Control group
NO INTERVENTIONParticipants in this group will consist of people who do not routinely do any practive on their own to reduce anxiety during intrauterine device insertion.
Interventions
Participants will view a specific relaxing and distracting scenario using virtual reality (VR) for approximately 7-8 minutes from one minute before the procedure until the end of the procedure. Assessment will be performed with STAI just before the intrauterine device insertion procedure, and again with STAI after the procedure.
Eligibility Criteria
You may qualify if:
- Volunteering to participate in the research
- Answering questionnaire and scale forms completely
- Read and understand Turkish
- years of age or older
- STAI score of 35 and above
- Not being pregnant,
- No complaints of acute pelvic pain,
- No damage or leysone in the perineum that may cause pain during examination,
- Not using a pharmacological agent or method with analgesic or anxiolytic effect 24 hours before the application,
- No vaginismus problem,
- Absence of a history of sexual abuse,
- Not having any physical or mental problems that may prevent communication.
You may not qualify if:
- Not volunteering to participate in the research,
- Incomplete responses to questionnaires and scale forms
- Not understanding Turkish,
- Under 18 years of age
- Do not score less than 35 points on the STAI,
- Don't be pregnant,
- Complaint of acute pelvic pain,
- Any damage or leysone in the perineum that may cause pain during examination,
- Having used a pharmacological agent or method with analgesic or anxiolytic effect 24 hours before the application,
- Having a vaginismus problem,
- Previous history of sexual abuse,
- Having any physical or mental problem that prevents communication.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
1.Murat State Hospital
Edirne, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
remzire karadogan, Midwife
Kırklareli University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 12, 2023
First Posted
December 21, 2023
Study Start
May 1, 2024
Primary Completion
September 25, 2024
Study Completion
September 26, 2024
Last Updated
October 8, 2024
Record last verified: 2024-10